Emil Kakkis
Founder chez ULTRAGENYX PHARMACEUTICAL INC.
Fortune : 132 M $ au 31/03/2024
Profil
Emil D. Kakkis a fondé Ultragenyx Pharmaceutical, Inc. et la Fondation Everylife pour les maladies rares. Le Dr Kakkis occupe le poste de président, directeur général et directeur d'Ultragenyx Pharmaceutical, Inc. Le Dr Kakkis est également membre du conseil d'administration d'Emil Kakkis & Jenny Soriano Living Trust et d'Odylia Therapeutics et président de la Everylife Foundation for Rare Diseases. Dans sa carrière antérieure, le Dr Kakkis a été directeur médical et vice-président principal de BioMarin Pharmaceutical, Inc. et professeur adjoint au Harbor-UCLA Medical Center. Le Dr Kakkis a obtenu un diplôme de premier cycle au Pomona College et un doctorat à la David Geffen School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/03/2024 | 2 827 898 ( 3,43% ) | 132 M $ | 31/03/2024 |
Postes actifs de Emil Kakkis
| Sociétés | Poste | Début |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Founder | 22/04/2010 |
| Emil Kakkis & Jenny Soriano Living Trust | Director/Board Member | - |
Everylife Foundation for Rare Diseases
 Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Founder | 01/03/2009 |
| Odylia Therapeutics | Director/Board Member | 01/01/2019 |
Anciens postes connus de Emil Kakkis
| Sociétés | Poste | Fin |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | 27/02/2009 |
Harbor-UCLA Medical Center
 Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Harbor-UCLA Medical Center provides medical practice, education, and research services. The private company is based in Torrance, CA. | Corporate Officer/Principal | 01/01/1998 |
Formation de Emil Kakkis
| Pomona College | Undergraduate Degree |
| David Geffen School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Harbor-UCLA Medical Center
Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Harbor-UCLA Medical Center provides medical practice, education, and research services. The private company is based in Torrance, CA. | Health Services |
| Emil Kakkis & Jenny Soriano Living Trust | |
Everylife Foundation for Rare Diseases
Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Commercial Services |
| Odylia Therapeutics |
